Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Psychopharmacology Bulletin VOL 49 No. 1, 2019 - Full Issue Stacked PDF
1
x
$
90.00
Clozapine Factors in Schizophrenia by Takefumi Suzuki
1
x
$
30.00
Zonisamide for Bipolar Disorder, Mania or Mixed States by Deborah Dauphinais
1
x
$
30.00
Long-Term Treatment Strategies in Anxiety Disorders
1
x
$
30.00
Agomelatine for Depression in Schizophrenia by Jochen Mutschler
1
x
$
30.00
Akathisia Induced by Abrupt Withdrawal of Risperidone: A Case Report
2
x
$
30.00
A Case of Clozapine Induced Mania-Like Symptoms in the Treatment of Schizophrenia
2
x
$
30.00
Effects of Venlafaxine on the Size of Brain and Expression of SHANK3, TUBB5 and DDC Genes in BALB/c Mice
1
x
$
30.00
Clinical Predictors of Response to Clozapine by Rajkumar A.P.
1
x
$
30.00
β-Blockers for Autism—Help or Hindrance?
1
x
$
30.00
Tyler M. McLeod, BS: Nitric Oxide, Stress, and Depression
1
x
$
30.00
The Use of Divalproex in the Treatment of Addictive Disorders
1
x
$
30.00
Paolo Castrogiovanni, MD: Can Serotonin and Fluoxetine Levels in Plasma and Platelets Predict Clinical Response in Depression?
1
x
$
30.00
Critical Analysis of Recent Phase III Studies for the Treatment of Colorectal Cancer Implications for Future Clinical Trial Design
1
x
$
10.00
View Cart
Checkout
Home
md-and
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
The Use of Divalproex in the Treatment of Addictive Disorders
$
30.00
Add to cart
Details
Page load link
Go to Top
